Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M
U.S. health agencies participated in WHO flu meeting despite planned exit
Teva targets schizophrenia to build on innovative medicines growth
*please scroll down for all the latest news*
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M
U.S. health agencies participated in WHO flu meeting despite planned exit
Teva targets schizophrenia to build on innovative medicines growth
*please scroll down for all the latest news*
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud